These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21590334)

  • 1. Novel biomarker candidates to predict hepatic fibrosis in hepatitis C identified by serum proteomics.
    Yang L; Rudser KD; Higgins L; Rosen HR; Zaman A; Corless CL; David L; Gourley GR
    Dig Dis Sci; 2011 Nov; 56(11):3305-15. PubMed ID: 21590334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel serum biomarker candidates for liver fibrosis in hepatitis C patients.
    Gangadharan B; Antrobus R; Dwek RA; Zitzmann N
    Clin Chem; 2007 Oct; 53(10):1792-9. PubMed ID: 17702858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SRM targeted proteomics in search for biomarkers of HCV-induced progression of fibrosis to cirrhosis in HALT-C patients.
    Qin S; Zhou Y; Lok AS; Tsodikov A; Yan X; Gray L; Yuan M; Moritz RL; Galas D; Omenn GS; Hood L
    Proteomics; 2012 Apr; 12(8):1244-52. PubMed ID: 22577025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New approaches for biomarker discovery: the search for liver fibrosis markers in hepatitis C patients.
    Gangadharan B; Antrobus R; Chittenden D; Rossa J; Bapat M; Klenerman P; Barnes E; Dwek RA; Zitzmann N
    J Proteome Res; 2011 May; 10(5):2643-50. PubMed ID: 21410221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel biomarkers predict liver fibrosis in hepatitis C patients: alpha 2 macroglobulin, vitamin D binding protein and apolipoprotein AI.
    Ho AS; Cheng CC; Lee SC; Liu ML; Lee JY; Wang WM; Wang CC
    J Biomed Sci; 2010 Jul; 17(1):58. PubMed ID: 20630109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary study.
    Gangadharan B; Bapat M; Rossa J; Antrobus R; Chittenden D; Kampa B; Barnes E; Klenerman P; Dwek RA; Zitzmann N
    PLoS One; 2012; 7(6):e39603. PubMed ID: 22761838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum proteomic MRM identify peptide ions of transferrin as new fibrosis markers in chronic hepatitis B.
    Xu MY; Qu Y; Jia XF; Wang ML; Liu H; Wang XP; Zhang LJ; Lu LG
    Biomed Pharmacother; 2013 Sep; 67(7):561-7. PubMed ID: 23639231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum vitamin D₃ does not correlate with liver fibrosis in chronic hepatitis C.
    Ren Y; Liu M; Zhao J; Ren F; Chen Y; Li JF; Zhang JY; Qu F; Zhang JL; Duan ZP; Zheng SJ
    World J Gastroenterol; 2015 Oct; 21(39):11152-9. PubMed ID: 26494969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of hepatic iron deposition and serum iron values in patients with chronic hepatitis C infection.
    Metwally MA; Zein CO; Zein NN
    Am J Gastroenterol; 2004 Feb; 99(2):286-91. PubMed ID: 15046219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxiredoxin 2: a potential biomarker for early diagnosis of hepatitis B virus related liver fibrosis identified by proteomic analysis of the plasma.
    Lu Y; Liu J; Lin C; Wang H; Jiang Y; Wang J; Yang P; He F
    BMC Gastroenterol; 2010 Oct; 10():115. PubMed ID: 20939925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infection.
    White IR; Patel K; Symonds WT; Dev A; Griffin P; Tsokanas N; Skehel M; Liu C; Zekry A; Cutler P; Gattu M; Rockey DC; Berrey MM; McHutchison JG
    J Transl Med; 2007 Jul; 5():33. PubMed ID: 17625010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential proteomic biomarkers in assessing liver fibrosis using SELDI-TOF MS.
    Karatayli SC; Alagöz SG; Mizrak D; Sayki M; Ozkan M; Savaş B; Erden E; Cinar K; Idılman R; Yurdaydin C; Bozdayi AM
    Turk J Gastroenterol; 2012 Feb; 23(1):46-53. PubMed ID: 22505379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited reliability of five non-invasive biomarkers in predicting hepatic fibrosis in chronic HCV mono-infected patients opposed to METAVIR scoring.
    Elesawy BH; Abd El Hafez A; Dorgham LS; El-Askary A
    Pathol Res Pract; 2014 Dec; 210(12):922-8. PubMed ID: 25123964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.
    D'Souza RF; Feakins R; Mears L; Sabin CA; Foster GR
    Aliment Pharmacol Ther; 2005 Mar; 21(5):519-24. PubMed ID: 15740534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma Golgi protein 73 levels predict prognosis of HCV-related hepatic fibrosis.
    Liu L; Al-Dhamin Z; Yuan X; Cui L; Yang Y; Zhao W; Zhang Y; Fu N; Nan Y
    Histol Histopathol; 2020 Nov; 35(11):1309-1318. PubMed ID: 33063838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum osteopontin predicts degree of hepatic fibrosis and serves as a biomarker in patients with hepatitis C virus infection.
    Matsue Y; Tsutsumi M; Hayashi N; Saito T; Tsuchishima M; Toshikuni N; Arisawa T; George J
    PLoS One; 2015; 10(3):e0118744. PubMed ID: 25760884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Proteomic Changes as Candidate Biomarkers of Intermediate Liver Fibrosis in Chronic Hepatitis B Infection.
    Dai YN; Tu YX; Meng D; Chen MJ; Zhang JJ; Gong YH; Tong YX; Wang MS; Pan HY; Huang HJ
    OMICS; 2019 Mar; 23(3):167-179. PubMed ID: 30883302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma gelsolin protein: a candidate biomarker for hepatitis B-associated liver cirrhosis identified by proteomic approach.
    Marrocco C; Rinalducci S; Mohamadkhani A; D'Amici GM; Zolla L
    Blood Transfus; 2010 Jun; 8 Suppl 3(Suppl 3):s105-12. PubMed ID: 20606740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Plasma proteome analysis of chronic hepatitis B patients with different stages of liver fibrosis].
    Jia XF; Lu W; Yin L; Yuan ZH; Zhang LJ; Zhang ZQ
    Zhonghua Gan Zang Bing Za Zhi; 2012 Sep; 20(9):659-63. PubMed ID: 23207229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic potential of serum matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as non-invasive markers of hepatic fibrosis in patients with HCV related chronic liver disease.
    El-Gindy I; El Rahman AT; El-Alim MA; Zaki SS
    Egypt J Immunol; 2003; 10(1):27-35. PubMed ID: 15719620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.